Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Mutation research

• Publication date

  2005-05-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MRFMMM.2004.08.015PMID 15790486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis

  2003cited by this paper
• Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.

  2002cited by this paper
• Anaphylaxis in the United States: an investigation into its epidemiology.

  2001cited by this paper
• Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy.

  2001cited by this paper
• ANAPHYLAXIS AND ANAPHYLACTOID REACTIONS

  2000cited by this paper
• Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.

  2000cited by this paper
• A novel assay for allelic discrimination that combines the fluorogenic 5' nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay.

  1999cited by this paper
• Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts

  1999cited by this paper
• Clinical correlates of the presence of the asp816Val c‐kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis

  1998cited by this paper
• Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

  1998cited by this paper
• The clinical spectrum of anaphylaxis in north‐west England

  1996cited by this paper
• Mast Cells and Basophils: Their Role in Initiating and Maintaining Inflammatory Responses

  1995cited by this paper
• Immunopharmacology of the respiratory system

  1995cited by this paper
• Anaphylaxis. A review of 266 cases.

  1995cited by this paper
• Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

  1993cited by this paper

• Towards a Multi-omics Understanding of Anaphylaxis: Insights into Pathogenesis and Biomarker Identification

  2025cites this paper
• Disease correlates and clinical relevance of Hereditary Alpha-Tryptasemia in patients with Systemic Mastocytosis.

  2022cites this paper
• Detection of clonal mast cell disease in wasp venom allergic patients with normal tryptase

  2022cites this paper
• Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series

  2021cites this paper
• Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients.

  2017cites this paper
• Mast cells and their activation in lung disease.

  2016cites this paper
• Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.

  2015cites this paper
• Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.

  2015cites this paper
• The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.

  2015cites this paper
• Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

  2014cites this paper
• A concise, practical guide to diagnostic assessment for mast cell activation disease

  2014cites this paper
• Therapeutic targeting of c-KIT in cancer

  2013cites this paper
• Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis.

  2013cites this paper
• Review article: Mast cell activation disease

  2013cites this paper
• Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions

  2012cites this paper
• Reactivating PP2A by FTY720 as a Novel therapy for AML with C‐KIT tyrosine kinase domain mutation

  2012cites this paper
• Wykorzystanie badania ekspresji genów metodą mikromacierzy RNA w ocenie efektywności immunoterapii swoistej jadem owadów, rozpoznaniu mastocytozy i ocenie zagrożenia alergią na jady owadów u chorych na mastocytozę

  2011cites this paper
• Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

  2011cites this paper
• Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis

  2011cites this paper
• Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases

  2010cites this paper
• The Angiotensinogen AGT p.M235T Gene Polymorphism May Be Responsible for the Development of Severe Anaphylactic Reactions to Insect Venom Allergens

  2010cites this paper
• Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

  2010cites this paper
• GDAŃSKI UNIWERSYTET MEDYCZNY

  2009cites this paper
• Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders

  2008influential citation
• Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c‐KIT

  2008cites this paper
• Systembeteiligung bei Urticaria pigmentosa

  2007cites this paper
• Systemic mastocytosis: a concise clinical and laboratory review.

  2007cites this paper
• Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia, and Mast Cell Disease

  2007cites this paper
• Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

  2006cites this paper